These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32050280)

  • 41. A moderate 500-m treadmill walk for estimating peak oxygen uptake in men with NYHA class I-II heart failure and reduced left ventricular ejection fraction.
    Mazzoni G; Sassone B; Pasanisi G; Myers J; Mandini S; Volpato S; Conconi F; Chiaranda G; Grazzi G
    BMC Cardiovasc Disord; 2018 Apr; 18(1):67. PubMed ID: 29661150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cardiopulmonary exercise test grey zone; optimising fitness stratification by application of critical difference.
    Rose GA; Davies RG; Davison GW; Adams RA; Williams IM; Lewis MH; Appadurai IR; Bailey DM
    Br J Anaesth; 2018 Jun; 120(6):1187-1194. PubMed ID: 29793585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiopulmonary exercise testing during the COVID-19 pandemic.
    Mihalick VL; Canada JM; Arena R; Abbate A; Kirkman DL
    Prog Cardiovasc Dis; 2021; 67():35-39. PubMed ID: 33964290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the modified shuttle walk test and cardiopulmonary exercise test in sarcoidosis.
    de Boer S; Kolbe J; Wilsher ML
    Respirology; 2014 May; 19(4):604-7. PubMed ID: 24666931
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimated peak functional capacity: an accurate method for assessing change in peak oxygen consumption after cardiac rehabilitation?
    Nichols S; Gleadall-Siddall DO; Antony R; Clark AL; Cleland JGF; Carroll S; Ingle L
    Clin Physiol Funct Imaging; 2018 Jul; 38(4):681-688. PubMed ID: 28857391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The 1-min sit-to-stand test in cystic fibrosis - Insights into cardiorespiratory responses.
    Radtke T; Hebestreit H; Puhan MA; Kriemler S
    J Cyst Fibros; 2017 Nov; 16(6):744-751. PubMed ID: 28188010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases.
    Ferrazza AM; Martolini D; Valli G; Palange P
    Respiration; 2009; 77(1):3-17. PubMed ID: 19145106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part III: Interpretation of cardiopulmonary exercise testing in chronic heart failure and future applications.
    ;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):485-94. PubMed ID: 16874136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical interpretation of cardiopulmonary exercise testing in cystic fibrosis and implications for exercise counselling.
    Urquhart DS; Vendrusculo FM
    Paediatr Respir Rev; 2017 Sep; 24():72-78. PubMed ID: 26515919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel CPET Reference Values in Healthy Adults: Associations with Physical Activity.
    Wagner J; Knaier R; Infanger D; Königstein K; Klenk C; Carrard J; Hanssen H; Hinrichs T; Seals D; Schmidt-Trucksäss A
    Med Sci Sports Exerc; 2021 Jan; 53(1):26-37. PubMed ID: 32826632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The role of cardiopulmonary exercise testing in the assessment of pulmonary hypertension].
    Dumitrescu D; Rosenkranz S
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S176-9. PubMed ID: 18814090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evaluation of integrated cardiopulmonary exercise testing in a pulmonary function laboratory.
    Sridhar MK; Carter R; Banham SW; Moran F
    Scott Med J; 1995 Aug; 40(4):113-6. PubMed ID: 8787110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. B-type natriuretic peptides for the evaluation of exercise intolerance.
    Mueller C; Maeder MT; Christ A; Reichlin T; Staub D; Noveanu M; Breidthardt T; Potocki M; Brutsche MH
    Am J Med; 2009 Mar; 122(3):265-72. PubMed ID: 19272488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and feasibility of cardiopulmonary exercise testing in head and neck cancer survivors.
    Midgley AW; Levy AR; Cunha FA; Key A; Patterson JM; Rogers SN
    Clin Physiol Funct Imaging; 2023 May; 43(3):170-180. PubMed ID: 36533848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment for cardiovascular fitness in patients with stroke: which cardiopulmonary exercise testing method is better?
    Mustafa E; Aytür YK
    Top Stroke Rehabil; 2022 Jul; 29(5):347-355. PubMed ID: 34027834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiorespiratory optimal point: a submaximal variable of the cardiopulmonary exercise testing.
    Ramos PS; Ricardo DR; Araújo CG
    Arq Bras Cardiol; 2012 Nov; 99(5):988-96. PubMed ID: 23033112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiopulmonary exercise testing for evaluation of a randomized exercise training intervention following aortic valve replacement.
    Nilsson H; Nylander E; Borg S; Tamás É; Hedman K
    Clin Physiol Funct Imaging; 2019 Jan; 39(1):103-110. PubMed ID: 30298625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Which field walking test should be used to assess functional exercise capacity in lung cancer? An observational study.
    Granger CL; Denehy L; Parry SM; Martin J; Dimitriadis T; Sorohan M; Irving L
    BMC Pulm Med; 2015 Aug; 15():89. PubMed ID: 26264470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex-specific cardiopulmonary exercise testing indices related to hemodynamics in idiopathic pulmonary arterial hypertension.
    Yuan P; Chen TX; Pudasaini B; Zhang J; Guo J; Zhang SJ; Wang L; Zhao QH; Gong SG; Jiang R; Wu WH; He J; Liu JM; Hu QH
    Ther Adv Respir Dis; 2017 Mar; 11(3):135-145. PubMed ID: 28043202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension.
    Chen TX; Pudasaini B; Guo J; Gong SG; Jiang R; Wang L; Zhao QH; Wu WH; Yuan P; Liu JM
    Int J Chron Obstruct Pulmon Dis; 2018; 13():385-397. PubMed ID: 29416329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.